Innovation that matters
CRISPR Therapeutics (crisprtx.com) scores 79 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 64th percentile of 9949 Healthcare brands.
CRISPR Therapeutics is a biopharmaceutical company headquartered in Zug, Switzerland (also associated with Basel), founded in 2013. It focuses on translating CRISPR/Cas9 gene-editing technology into therapies for serious diseases, including hemoglobinopathies and cancer. The company positions itself as a pioneer in gene-editing science, working with healthcare providers, biopharmaceutical partners, and the broader medical and scientific community to develop potentially curative treatments.
| Brand Name | CRISPR Therapeutics |
|---|---|
| Domain | crisprtx.com |
| Industry | Healthcare |
| Founded | 2013 |
| Headquarters | Zug |
| Main Competitors | Intellia Therapeutics (84/100), Editas Medicine (82/100), Beam Therapeutics (76/100), Sangamo Therapeutics (84/100), bluebird bio (57/100), Vertex Pharmaceuticals (88/100) |
Moz Domain Authority 56/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #260,977 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
CRISPR Therapeutics has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "To pioneer CRISPR gene-editing technology into transformative therapies for patients with serious diseases." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram; no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is CRISPR Therapeutics?", Claude could identify the brand as of September 2026. CRISPR Therapeutics is a Switzerland-based biotechnology company that pioneers gene-editing therapies using CRISPR/Cas9 technology to treat serious human diseases. It co-developed Casgevy (exagamglogene autotemcel), the first FDA-approved CRISPR-based gene therapy, used to treat Best known for Co-developing Casgevy, the first FDA-approved CRISPR gene-editing therapy for sickle cell disease and beta thalassemia.
When asked "Best brands similar to CRISPR Therapeutics?", Claude would recommend CRISPR Therapeutics as of September 2026. It's a leading and pioneering name in CRISPR-based gene editing therapeutics, so it would naturally come up when discussing top gene therapy or biotech companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
CRISPR Therapeutics's main competitors in Healthcare: Intellia Therapeutics (84/100), Editas Medicine (82/100), Beam Therapeutics (76/100), Sangamo Therapeutics (84/100), bluebird bio (57/100).
Sources: Brand Analyzer scan
CRISPR Therapeutics has moderate AI-search visibility, scoring 61/100 on Brand Analyzer's AI visibility composite (visibility 68, trust 49, recommendation 62). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: CRISPR Therapeutics official site
CRISPR Therapeutics was founded in 2013. CRISPR Therapeutics operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
CRISPR Therapeutics is headquartered in Zug. CRISPR Therapeutics operates in the Healthcare category.
Sources: Wikidata
CRISPR Therapeutics scores 62/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: CRISPR Therapeutics official site
CRISPR Therapeutics is a biopharmaceutical company headquartered in Zug, Switzerland, founded in 2013. It focuses on developing gene-editing therapies based on CRISPR/Cas9 technology for the treatment of serious diseases such as hemoglobinopathies and cancer.
Sources: CRISPR Therapeutics official site
CRISPR Therapeutics develops therapies that use CRISPR/Cas9 gene-editing technology to treat serious diseases, including blood disorders like hemoglobinopathies and various forms of cancer. It works to translate this gene-editing science into potentially curative treatments for patients.
Sources: CRISPR Therapeutics official site
CRISPR Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: CRISPR Therapeutics official site
CRISPR Therapeutics offers gene-editing therapies based on CRISPR/Cas9 technology, targeting serious diseases such as hemoglobinopathies (blood disorders) and cancer. These are developed as potentially curative treatments rather than traditional pharmaceutical products.
Sources: CRISPR Therapeutics official site
CRISPR Therapeutics is known for being a pioneer in applying CRISPR/Cas9 gene-editing technology to the development of therapeutic treatments for serious diseases, particularly hemoglobinopathies and cancer.
Sources: CRISPR Therapeutics official site
CRISPR Therapeutics' work is intended for patients with serious genetic and other diseases, and it engages healthcare providers, biopharmaceutical partners, and the broader medical and scientific community in developing and advancing its gene-editing therapies.
Sources: CRISPR Therapeutics official site
CRISPR Therapeutics scores 61/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
CRISPR Therapeutics has a moderate AI-visibility profile at 61/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (68/100) and its weakest is trust (49/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #260,977 (Tranco). The main gaps holding it back: no llms.txt to steer AI to its best pages. In a live check, Claude could already identify CRISPR Therapeutics from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to CRISPR Therapeutics: CRB (79/100), CPC (Colder Products Company) (79/100), Cryoport Systems (79/100), Crystal Practice Management (79/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.